CME

Gastric Cancer: Enhanced Clinical Decision-Making Via Molecular Profiling
Maximum of 0.75 AMA PRA Category 1 Credit(s)™.
Topics — gastric cancer, Vindico

NSCLC: Individualizing Care Based on Patient and Tumor Characteristics
Maximum of 0.75 AMA PRA Category 1 Credit(s)™.

Hitting the Benchmarks in mCRC: A Precision Medicine Quality Initiative for the Care Team
0.75 CME/MOC/CC/NCPD/CPE/AAPA/IPCE
Topics — PeerView

Melanoma Oncolytic Immunotherapy: An Evolving Therapeutic Landscape
Maximum of 1.25 AMA PRA Category 1 Credit(s)™.

Project ECHO® Learning Series: Evolving Role of Bispecific Antibodies as Cancer Therapy
These activities will be CME/CPE/CNE-certified.

Project ECHO®: Pulmonary Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in May 2023

Project ECHO®: Dermatologic Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in April 2023

Project ECHO®: Hepatobiliary Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in March 2023

Project ECHO®: Neurological Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in February 2023

Project ECHO®: Rheumatologic Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in January 2023

Project ECHO®: Endocrine Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in November 2022

Project ECHO®: Gastroenterology Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in October 2022

Project ECHO®: Cardiovascular Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in September 2022

Project ECHO® Learning Series: Telementoring to Manage Immune-Related Adverse Events in Patients Receiving Cancer Immunotherapies
These activities will be CME/CPE/CNE-certified.

Optimizing Frontline Immunotherapy in Advanced Non-Small Cell Lung Cancer
Physician: .75 AMA PRA Category 1 Credit(s)™
Topics — NSCLC

Molecular Testing in the Community Oncology Setting
Content Derived from a CME Certified Webinar in June 2021